Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

P75 nerve growth factor receptor as a useful marker to distinguish spindle cell melanoma from other spindle cell neoplasms of sun-damaged skin.

Sigal AC, Keenan M, Lazova R.

Am J Dermatopathol. 2012 Apr;34(2):145-50. doi: 10.1097/DAD.0b013e318225b596.

PMID:
22207443
2.

P75 nerve growth factor receptor staining is superior to S100 in identifying spindle cell and desmoplastic melanoma.

Lazova R, Tantcheva-Poor I, Sigal AC.

J Am Acad Dermatol. 2010 Nov;63(5):852-8. doi: 10.1016/j.jaad.2009.11.688.

PMID:
20950740
3.

p75 nerve growth factor receptor staining helps identify desmoplastic and neurotropic melanoma.

Kanik AB, Yaar M, Bhawan J.

J Cutan Pathol. 1996 Jun;23(3):205-10.

PMID:
8793654
4.

p63 is a useful marker for cutaneous spindle cell squamous cell carcinoma.

Dotto JE, Glusac EJ.

J Cutan Pathol. 2006 Jun;33(6):413-7.

PMID:
16776716
5.

Utility of p63 in the differential diagnosis of atypical fibroxanthoma and spindle cell squamous cell carcinoma.

Gleason BC, Calder KB, Cibull TL, Thomas AB, Billings SD, Morgan MB, Hiatt KM, Smoller BR.

J Cutan Pathol. 2009 May;36(5):543-7. doi: 10.1111/j.1600-0560.2008.01099.x. Epub 2009 Mar 30.

PMID:
19476522
6.

Immunohistochemical distinction of cutaneous spindle cell carcinoma.

Morgan MB, Purohit C, Anglin TR.

Am J Dermatopathol. 2008 Jun;30(3):228-32. doi: 10.1097/DAD.0b013e31816de820.

PMID:
18496422
7.
8.
9.

Diagnostic utility of low-affinity nerve growth factor receptor (P 75) immunostaining in atypical fibroxanthoma.

Bull C, Mirzabeigi M, Laskin W, Dubina M, Traczyc T, Guitart J, Gerami P.

J Cutan Pathol. 2011 Aug;38(8):631-5. doi: 10.1111/j.1600-0560.2011.01718.x. Epub 2011 May 30.

PMID:
21623867
10.

Spindle cell neoplasm of skin: diagnostic dilemma.

Jain M, Singh S, Agarwal K.

Indian J Pathol Microbiol. 2007 Oct;50(4):814-6.

PMID:
18306566
11.

Melan-A: not a helpful marker in distinction between melanoma in situ on sun-damaged skin and pigmented actinic keratosis.

El Shabrawi-Caelen L, Kerl H, Cerroni L.

Am J Dermatopathol. 2004 Oct;26(5):364-6.

PMID:
15365366
12.

NGFR (p75) expression in cutaneous scars; Further evidence for a potential pitfall in evaluation of reexcision scars of cutaneous neoplasms, in particular desmoplastic melanoma.

Otaibi S, Jukic DM, Drogowski L, Bhawan J, Radfar A.

Am J Dermatopathol. 2011 Feb;33(1):65-71. doi: 10.1097/DAD.0b013e3181dfcb9f.

PMID:
21178583
15.
16.

Expression of S100A6 protein in a broad spectrum of cutaneous tumors using tissue microarrays.

Fullen DR, Garrisi AJ, Sanders D, Thomas D.

J Cutan Pathol. 2008 Nov;35 Suppl 2:28-34. doi: 10.1111/j.1600-0560.2007.00866.x. Epub 2008 Jan 14.

17.

Spindle-cell non-pleomorphic atypical fibroxanthoma: analysis of a series and delineation of a distinctive variant.

Calonje E, Wadden C, Wilson-Jones E, Fletcher CD.

Histopathology. 1993 Mar;22(3):247-54.

PMID:
7684354
18.
19.

Microphthalmia transcription factor: not a sensitive or specific marker for the diagnosis of desmoplastic melanoma and spindle cell (non-desmoplastic) melanoma.

Granter SR, Weilbaecher KN, Quigley C, Fletcher CD, Fisher DE.

Am J Dermatopathol. 2001 Jun;23(3):185-9.

PMID:
11391097
20.

Best practices in diagnostic immunohistochemistry: pleomorphic cutaneous spindle cell tumors.

Folpe AL, Cooper K.

Arch Pathol Lab Med. 2007 Oct;131(10):1517-24. Review.

PMID:
17922587

Supplemental Content

Support Center